| 24907 | T3RSO | T3 Reverse (RT3) | Triiodothyronine, Reverse
| | | 23070 | T3-A | T3, Total | Triiodothyronine, T-3, T3 Uptake, T3 Total
| | | 25562 | TACRO | Tacrolimus | FK506, Prograf
| | | 26154 | TDPU | Targeted Drug Panel, Urine | Drug screen, drug test, amines, amphetamine, methamphetamine, benzodiazepines, opiates, opioids
| Definitive/confirmatory panel to semi-quantitatively detect the use of amines/amphetamines, benzodiazepines, and opioids drug classes using Liquid Chromatography-Tandem Mass Spectrometry methodology. Quantitative results are not available, but drugs detected as “present” will be reported with a quantitative range in which it was detected.
Please see this document for a full list of drugs included in this panel, along with the detection levels of each: TDPU Test Components
NOTE: If other drug classes are also of interest (cannabinoids, cocaine, barbiturates, ethanol), it is recommended that the PCS4WO test be ordered along with this test.
| | 26389 | COGTFSO | T-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), Children's Oncology Group Enrollment Testing, FISH, Varies (COGTF) | 9p- (9p deletion) or CDKN2A or p16, t(9;22)(q34;q11.2) - BCR/ABL1, MLL or KMT2A (11q23) rearrangement, t(4;11)(q21;q23) - AFF1/MLL or AFF4/MLL, t(6;11)(q27;q23) - MLLT4(AFDN)/MLL or AFDN/MLL, t(9;11)(p22;q23) - MLLT3/MLL or AF9/MLL, t(10;11)(p13;q23) - MLLT10/MLL, t(11;19)(q23;p13.3) - MLL/MLLT1 or MLL/ENL, t(11;19)(q23;p13.1) - MLL/ELL, 17p- (17p deletion) or TP53, t(5;14)(q35;q32) - TLX3/BCL11B or HOX11L2/BCL11B, T-cell receptor beta (TRB) (7q34) rearrangement, T-cell receptor alpha/delta (TRAD) (14q11.2) rearrangement, t(10;11)(p13;q14) - MLLT10/PICALM or AF10/PICALM, TAL1/STIL (1p33) rearrangement or TAL/SIL, Children's Oncology Group, COG | This test is only performed on specimens from pediatric patients being considered for enrollment in a Children's Oncology Group (COG) protocol. The fluorescence in situ hybridization (FISH) panel includes testing for the following abnormalities using the FISH probes listed: +9/9p-, CDKN2A/D9Z1 t(9;22) or ABL1 amplification, ABL1/BCR 11q23 rearrangement, MLL (KMT2A) break-apart -17/17p-, TP53/D17Z1 t(5;14), TLX3/BCL11B fusion 7q34 rearrangement, TRB break-apart 14q11.2 rearrangement, TRAD break-apart t(10;11), MLLT10/PICALM fusion 1p33 rearrangement, TAL1/STIL When an MLL (KMT2A) rearrangement is identified, reflex testing will be performed to identify the translocation partner. Probes include identification of: t(11;19)(q23;p13.3) MLL/MLLT1 t(6;11)(q27;q23) MLLT4(AFDN)/MLL t(4;11)(q21;q23) AFF1/MLL t(9;11)(p22;q23) MLLT3/MLL t(10;11)(p12;q23) MLLT10/MLL t(11;19)(q23;p13.1) MLL/ELL When a TRAD rearrangement is identified, reflex testing will be performed to identify the translocation partner. Probes include identification of: t(11;14)(p15;q11.2) LMO1/TRAD t(8;14)(q24.1;q11.2) MYC/TRAD t(10;14)(q24;q11.2) TLX1(HOX11)/TRAD t(11;14)(p13;q11.2) LMO2/TRAD When a TRB rearrangement is identified, reflex testing will be performed to identify the translocation partner. Probes include identification of: t(7;10)(q34;q24) TRB/TLX1 t(7;11)(q34;p15) TRB/LMO1 t(7;11)(q34;p13) TRB/LMO2 t(6;7)(q23;q34) MYB/TRB In the absence of BCR/ABL1 fusion or apparent episomal ABL1 amplification, when an extra ABL1 signal is identified, reflex testing will be performed using the ABL1 break-apart probe set to evaluate for the presence or absence of an ABL1 rearrangement. | | 25624 | TCGRVSO | T-Cell Receptor Gene Rearr, PCR, Varies (TCGRV) | Lymphoma vs Benign Process, Reactive Lymphocytic Process, T-Cell Gene Rearrangement, TCGRV, T Cell Gene Rearrangement, T Cell Clonality
| | | 25625 | TCGRSO | T-Cell Receptor Gene Rearrange, PCR, Bld (TCGR) | Lymphoma vs Benign Process, Reactive Lymphocytic Process, T-Cell Gene Rearrangement, T Cell Gene Rearrangement
| | | 22519 | HSRAT | T-Cell Subsets (CD4/CD8 Ratio) | Flow Cytometry, Helper T-Lymphocyte, CD4, T-cell subsets, CD4/CD8 Count, Antibody Monitoring
| | | 26162 | TEG6S | TEG 6S Citrated K, KH, RT, FF | | Kaolin TEG (R, K, Angle, MA), Kaolin TEG with Heparinase to neutralize heparin (RH), Functional Fibrinogen Maximum Amplitude (FFMA), and Rapid TEG (MA-RT) | | 26164 | TEG | TEG Citrated Kaolin on 5000 | TEG, Thromboelastography | Kaolin TEG (R, K, angel, MA, LY30) | | 26167 | TEGCFF | TEG Kaolin w/Functional FIB | | Kaolin TEG and Functional Fibrinogen (R, K, Angle, MA, LY30, FF-MA) | | 26165 | TEGHEP | TEG Kaolin w/Heparinase | | Kaolin TEG with Heparinase (R-H, K-H, ANG-H, MA-H, and LY30H) | | 26182 | TEGHCFF | TEG Kaolin+Func FIB w/Heparinase | Heparinase TEG, TEG Heparinase, TEG Trauma | Kaolin TEG+ Citrated Functional Fibrinogen with Heparinase (R-H, K-H, ANG-H, MA-H, LY30H, FF-MA) | | 23077 | FT | Testosterone, Free (Includes Total and SHBG) | Free Testosterone, Testosterone Panel, Tot & Free
| Testosterone, Sex Hormone Binding Globulin | | 23078 | TEST | Testosterone, Total | | | | 26404 | TTSTSO | Testosterone, Total, Mass Spectrometry, Serum (TTST) | Androgens Testosterone, Total Serum Testosterone, Total Only, Serum Testosterone Testosterone Group | | | 22332 | TETABSO | Tetanus Toxoid IgG Antibody (TTIGS) | Anti-tetanus toxoid, C. tetani, Clostridium tetani, Tetanus Immune Response, Tetanus toxoid antibodies
| | | 23079 | MISC | Thallium, 24 Hour, Urine (TLU) | Tl (Thallium)
| | | 25218 | TOTHIA | Thiamine (Vitamin B1), Whole Blood | Thiamin, Vitamin B1, Thiamine | | | 26570 | THIOSO | Thiopurine Metabolites, Whole Blood (THIO) | Thiopurine, Purinethol, Mercaptopurine, 6-MP, 6MP, 6-Thioguanine, Thioguanine, 6-TGN, 6-TG, 6TGN, 6TG, 6-Methylmercaptopurine, Methylmercaptopurine, 6-MMP, 6-MMPN, 6MMPN, 6MMP, Purine antimetabolites, THIO, TPRBC, Thiopurine Metabolites, 6-Mercaptopurine, FPMET
| 6-Thioguanine Nucleotides 6-Methylmercaptopurine
| | 26569 | TPNUQSO | Thiopurine Methyltransferase (TPMT) & Nudix Hydrolase (NUDT15) Genotyping, Varies (TPNUQ) | 6-Mercaptopurine; 6-Thioguanine; Acute Lymphoblastic Leukemia (ALL); Azathioprine; Crohn's Disease; Inflammatory Bowel Disease (IBD); NUDT15; Rheumatoid Arthritis; Thiopurine; TPMT; Ulcerative Colitis; Mercaptopurine; thioguanine; tmpt
| | | 26572 | TPMT3SO | Thiopurine Methyltransferase Activity Profile, Erythrocytes (TPMT3) | Azathioprine toxicity, Imuran toxicity, Mercaptopurine (6-MP) toxicity, Purinethol toxicity, Thioguanine (6-TG) toxicity, Thiopurine resistance, Myelosuppression, Hematopoietic toxicity, TPMT (Thiopurine Methyltransferase), TPMT Phenotype, Liver toxicity, TPMT enzyme
| 6-Methylmercaptopurine 6-Methylmercaptopurine riboside 6-Methylthioguanine riboside
| | 23082 | THIORID | Thioridazine and Mesoridazine (119) | Mellaril®
| | | 23083 | MISC | Thiothixene (120) | Navane® | | | 26276 | TTSCSO | Thrombin Time, Plasma (TTSC) | | | | 26604 | THSD7SO | Thrombospondin Type-1 Domain-Containing 7A Antibodies, Serum (THSD7) | Anti-THSD7A; THSD7A; Thrombospondin
| | | 25118 | MISC | Thyroglobulin - Other Fluids | Thyro, Fine Needle Aspirate, FNA, TG, Fluid, Cyst
| | | 23086 | TA-TG | Thyroglobulin Antibody | Thyroglobulin (Tg) Antibody, Anti-Thyroglobulin Antibody, Anti-TG
| | | 26585 | TGMSSO | Thyroglobulin Mass Spectrometry, Serum (TGMS) | HTG (Human Thyroglobulin)
TATC (Thyroglobulin Assay for Thyroid Cancer) TG (Thyroglobulin) Thyroglobulin Assay for Thyroid Cancer Thyroglobulin HTC (Human Thyro) | | | 23085 | THYGL | Thyroglobulin Tumor Marker & Anti-TG | TG, Thyroglobulin assay for thyroid cancer, Thyro, Thyrogl Tumor Marker & Anti-TG
| Thyroglobulin, Anti-Thyroglobulin | | 26468 | HTGRSO | Thyroglobulin, Tumor Marker Reflex, Serum (HTGR) | Anti Thyroglobulin Antibody, HTG (Human Thyroglobulin), TG (Thyroglobulin), Thyroglobulin Antibody, Thyroglobulin Assay for Thyroid Cancer, Thyroglobulin HTC (Human Thyro)
| This test begins with the analysis of thyroglobulin antibody by immunoassay. If the thyroglobulin antibody result is negative (<1.8 IU/mL), then thyroglobulin testing will be performed by immunoassay. If the thyroglobulin antibody result is positive (> or =1.8 IU/mL), then thyroglobulin testing will be performed by mass spectrometry. | | 23087 | TA-TPO | Thyroid Antibody (Anti-TPO) | Anti-TPO, Anti-thyroperoxidase, Microsomal antibody | | | 25438 | THYDC | Thyroid Diagnostic Cascade | TSH, Thyrotropin, Free-T4, Thyroid reflex
| 3rd Gen TSH, and when indicated Free-T4 (Free Thyroxine) | | 24789 | T7 | Thyroid Index Panel (T7, T4, T3 Uptake for OB) | T7, Free Thyroxine Index, FTI | T4, T3 Uptake | | 23088 | TSH | Thyroid Stimulating Hormone | TSH, Thyrotropin, s-TSH
| | | 23089 | TSI | Thyroid Stimulating Immunoglobulin, Serum (TSI) | Autoimmune Thyroid Stimulator, Graves Disease, LATS (Long-Acting Thyroid Stimulator), Long-Acting Thyroid Stimulator (LATS), TSH Receptor Binding Inhibitory Immunoglobulin, TSI (Thyroid-Stimulating Immunoglobulin), Thyretain, Thyrotropin receptor auto-antibody, Thyroid stimulating auto-antibody
| | | 26403 | TPOSO | Thyroperoxidase Antibodies, Serum (TPO) | Hashimoto Disease Microsomal Antibodies Thyroid Antibody Group Thyroid Peroxidase Antibody Thyroperoxidase Antibody, Serum TPO (Thyroperoxidase) Antibodies Thyroid Microsomal Antibodies Antithyroid Antibodies | | | 23190 | THRECSO | Thyrotropin Receptor Antibody (THYRO) | Antibodies to TSH receptor, Inhibitory Immunoglobulin, Long-Acting Thyroid Stimulator (LATS), TBII (TSH-Binding Inhibiting Immunoglobulin), Thyroid-Stimulating Hormone Receptor (TSH Receptor) Antibody, TRAb (Thyrotropin Receptor Antibody), TSH (Thyroid-Stimulating Hormone) Receptor Binding, TSH Binding Inhibition Index, TSH Receptor (Thyroid-Stimulating Hormone Receptor) Antibody, TSH-Binding Inhibiting Immunoglobulin (TBII), Graves Disease
| | | 23091 | T4-FREE | Thyroxine, Free | Free-T4, Free thyroxine, FT4
| | | 23241 | ZT4DIAL | Thyroxine, Free by Dialysis (FRT4D) | Free T4 (Thyroxine), FT4 by Dialysis, FT4 by Equilibrium Dialysis, FT4 by Tandem Mass Spectrometry, T4 (Thyroxine) Free,
T4 by Dialysis, Thyroxine (T4), Total or Free, ZT4DIAL
| | | 22926 | T-4 | Thyroxine, Total | T4 - Thyroxine, Total | | | 26422 | FGTIASO | Tiagabine (Gabitril), Serum (FGTIA) | | | | 25057 | TICKP | Tick Borne Panel (Does not include Lyme disease testing at this time) | Anaplasma phagocytophilum, Babesia microti, Babesiosis, Ehrlichia/Anaplasma
| ANENAT -Anaplasma phagocytophilum, Ehrlichia species
BABNAT - Babesia microti | | 26483 | TICKSSO | Tick-Borne Disease Antibodies Panel, Serum (TICKS) | Babesia microti, Borrelia burgdorferi, E. chaffeensis, Lyme Disease, Tick-Borne Diseases, Western Blot Assay, Spirochetes, Anaplasma phagocytophilum, HME (Human Monocytotropic Ehrlichiosis), Human Granulocytic Anaplasmosis (HGA)
| Ehrlichia chaffeensis (HME) Ab IgG, Anaplasma phagocytophilum Ab IgG, Babesia microti Ab IgG, Lyme Disease Serology If the Lyme disease screen result is positive or equivocal, then Lyme disease antibody confirmation by immunoblot will be performed at an additional charge. | | 23063 | HMISC | Tissue Immunohistochemistry, Surgical Pathology | Histology, Immunohistochemistry, IHC, Surgical Pathology, Paraffin Blocks
| | | 23233 | TTGAB | Tissue Transglutaminase AB, IgA and IgG | tTG Ab, celiac disease, sprue
| | | 22934 | TTG-IGA | Tissue Transglutaminase IgA Antibody | Sprue, Celiac, tTG IgA
| Tissue Transglutaminase IgA Antibodies | | 25421 | TTG-IGG | Tissue Transglutaminase IgG Antibody | Sprue, Celiac, tTG
| Tissue Transglutaminase IgG Antibodies | | 26205 | TOBPASO | Tobramycin, Peak, Serum (TOBPA) | Antibiotic Assay
Antimicrobial Assay, Tobramycin
Nebcin (Tobramycin Sulfate Injection)
Tobramycin, Antimicrobial Assay | | | 26206 | TOBRASO | Tobramycin, Random, Serum (TOBRA) | Antibiotic Assay
Antimicrobial Assay
Nebcin (Tobramycin Sulfate Injection)
Tobramycin, Random, Serum | | | 26202 | TOBTASO | Tobramycin, Trough, Serum (TOBTA) | Antibiotic Assay
Antimicrobial Assay
Antimicrobial Assay, Tobramycin
Nebcin (Tobramycin Sulfate Injection)
Tobramycin, Trough, Serum | | | 22928 | TOPIRSO | Topiramate, Serum (TOPI) | Topamax (Topiramate), Topiramate (Topamax)
| | | 24902 | TLCUSO | Total Light Chains, Urine (TLCU) | Immunoglobulin Light Chains, Kappa Light Chains, Lambda Light Chains, Light Chains, Kappa and Lambda, Urine Light Chains,
Immunoglobulin Total Light Chains, Urine U TLCUSO | | | 26541 | TOXCGSO | Toxocara Antibody, IgG, Serum | Ocular toxocariasis
TOXOC Toxocara canis Toxocariasis Visceral toxocariasis
| | | 22930 | TOXO | Toxoplasma Antibodies, IgG and IgM | Toxoplasmosis Antibodies, Toxoplasma gondii, Toxoplasmosis, IgG/IgM
| | | 26503 | PTOXSO | Toxoplasma gondii PCR (PTOX) | Toxoplasma gondii (T. gondii)
| | | 23202 | TRAM | Tramadol Quantitation, Urine | Ultracet, Ultram
| | | 22931 | TRANSF | Transferrin | Iron-Binding Protein | | | 22932 | STFRSO | Transferrin Receptors, Soluble (STFR) | sTfR (soluble transferrin receptor)
| | | 22933 | TXRX | Transfusion Reaction Workup | TRANSFUSION REACTION TxRx | ABO/RH, DAT | | 26095 | TRAZSO | Trazodone, Serum or Plasma (124) | Desyrel, Oleptro
| Serum or plasma test for Trazodone. | | 26540 | TRCNGSO | Trichinella Antibody, IgG, Serum | | | | 26610 | TVRNASO | Trichomonas vaginalis, Nucleic Acid Amplification, Varies | Trichomonas RNA, T. Vag, Trich | | | 26521 | MTRNASO | Trichomonas vaginalis, Nucleic Acid Amplification, Varies (MTRNA) | T vag, Trichomoniasis, Trich
| | | 25480 | TRICNAM | Trichomonas vaginalis, Nucleic Acid Method (NAM) | Trichomonas
| | | 23067 | TRIG | Triglycerides | | | | 23068 | TRIG-O | Triglycerides, Body Fluid | Chyle (Chylous Effusion), Chylomicrons in Body Fluid, Body Fluid Trig | | | 23069 | T3-FREE | Triiodothyronine, Free | T-3, Free, T-3 Free, Free T3, FT3
| | | 25029 | WHIPPSO | Tropheryma whipplei, PCR (TWRP) | | | | 22935 | TNI | Troponin I | High sensitivity troponin, TNIOH, TNI2H
| | | 26418 | TRPSSO | Troponin T, 5th Generation, Plasma (TRPS) | | | | 22936 | NEOTRP | TRP (Tubular Reabsorption of Phosphorus) | | Tests performed include serum and urine phosphorus, serum and urine creatinine plus a calculation for percent tubular reabsorption of phosphorus. | | 23096 | TRYPT | Tryptase, Serum (TRYPT) | Mast Cell Tryptase
| | | 26393 | TURKSO | Turkey, IgE, Serum (TURK) | Meleagris Gallopavo, Turkey, IgE, Serum (TURK)
| | | 26431 | FCTURSO | Turmeric (Curcuma longa) IgE (FCTUR) | Curcuma longa, Turmeric (Curcuma longa) IgE (FCTUR) | | | 26302 | T+S | Type and Screen (Transfusion Services) | T and S, Type and Screen, Type and Cross, Type and Hold
| | | 22937 | T-S | Type and Screen- Preop/Outpt Txn | T and S, Type and Screen, Type and Cross, Type and Hold, Type & Screen-Preop/Outpt Txn
| ABO/RH, ABSC | | 22938 | TZANCK | Tzanck Stain | Stain for Multinucleated Giant Cells | |
|